HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (4- azidobenzoylglycyl)- S- (2- thiopyridyl)cysteine (AGTC)

structure given in first source

Also Known As:

AGTC; L-Alanine, N-(N-(4-azidobenzoyl)glycyl)-3-(2-pyridinyldithio)-

Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Nitrogen Compounds: 67
  - Azides: 384
    - N-(4-azidobenzoylglycyl)-S-(2-thiopyridyl)cysteine: 8
Organic Chemicals: 133
- Azides: 384
  - N-(4-azidobenzoylglycyl)-S-(2-thiopyridyl)cysteine: 8

Experts

1.	Chulay, Jeffrey D: 5 articles (01/2020 - 03/2016)
2.	Knop, David R: 5 articles (01/2020 - 03/2016)
3.	Robinson, Paulette M: 5 articles (01/2020 - 03/2016)
4.	Shearman, Mark S: 3 articles (01/2020 - 01/2017)
5.	Ye, Guo-Jie: 3 articles (01/2020 - 01/2017)
6.	Hauswirth, William W: 3 articles (12/2018 - 03/2016)
7.	Sonnentag, Peter: 3 articles (12/2018 - 03/2016)
8.	Song, Chunjuan: 2 articles (01/2020 - 12/2018)
9.	Timmers, Adrian: 2 articles (01/2020 - 12/2018)
10.	Mandapati, Savitri: 2 articles (12/2018 - 03/2016)

Related Diseases

1.	Photophobia (Light Sensitivity) 01/01/2017 - "Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector expressing the human CNGA3 gene designated AGTC-402 (rAAV2tYF-PR1.7-hCNGA3) for the treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. " 03/01/2016 - "Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated viral (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. " 03/01/2016 - "Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. "
2.	Color Vision Defects (Color Blindness) 01/01/2017 - "Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector expressing the human CNGA3 gene designated AGTC-402 (rAAV2tYF-PR1.7-hCNGA3) for the treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. " 03/01/2016 - "Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated viral (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. " 03/01/2016 - "Applied Genetic Technologies Corporation (AGTC) is developing rAAV2tYF-PR1.7-hCNGB3, a recombinant adeno-associated virus (rAAV) vector expressing the human CNGB3 gene, for treatment of achromatopsia, an inherited retinal disorder characterized by markedly reduced visual acuity, extreme light sensitivity, and absence of color discrimination. "
3.	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/01/2020 - "Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated rAAV2tYF-GRK1-hRPGRco, to treat X-linked retinitis pigmentosa (XLRP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. " 12/01/2018 - "Applied Genetic Technologies Corporation (AGTC) is developing a recombinant adeno-associated virus (rAAV) vector AGTC-501, also designated AAV2tYF-GRK1-RPGRco, to treat retinitis pigmentosa (RP) in patients with mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene. "
4.	Starvation 10/14/2021 - "agsB, which encodes a putative α-1,3-glucan synthase, and two adjacent genes (agtC and gnsA) were upregulated under conditions of nitrogen starvation. "
5.	Schizophrenia (Dementia Praecox) 09/01/2017 - "Our results revealed genetic main effect of FKBP5 risk alleles (A allele of rs9296158 and T allele of rs3800373) and AGTC "risk" haplotype combination (rs9296158, rs3800373, rs9470080 and rs737054, respectively) on schizophrenia, particularly when childhood trauma was set as a confounding factor. "

Related Drugs and Biologics

1.	Retinaldehyde (Retinal)
2.	GTP Phosphohydrolases (GTPases)
3.	Nitrogen